CLINICAL_TRIALS
research
· 2014-09-19
Clinical Trial Update: Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)
Summary
An observational study evaluating functional benign prostatic hyperplasia symptoms in patients who switched from phytotherapy to ALNA (tamsulosin) has been comp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Prostatic Hyperplasia | Status: COMPLETED